Intra Uterine Growth Restriction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

31052 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-01

Study Completion Date

2019-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intrauterine growth restriction (IUGR) is associated with an increase in perinatal mortality and morbidity, as well as longer-term neurological, cognitive, cardiovascular and endocrine complications. In Europe, about 400,000 pregnancies per year are complicated by IUGR. However, antenatal diagnosis seems insufficient in clinical practice, making it impossible to recognize up to 75% of foetuses with IUGR. At a time when the use of good clinical practice has demonstrated a significant improvement in neonatal survival without severe morbidity, foetuses with IUGR are less likely to receive optimal care. Our hypothesis is that the rate of IUGR diagnosed underestimates the rate of actual IUGR.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Longitudinal Study of Intra-Uterine Growth Restriction

NCT02382601

IUGR Pregnancy

RECRUITING

Ultrasound Evaluation of Fetal Hemodynamics and Perinatal Complications

NCT03865628

Intrauterine Growth Restriction Small-for-gestational Age

UNKNOWN

Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.

NCT01995968

Stillbirth Intrauterine Growth Retardation Infant, Small for Gestational Age

UNKNOWN

Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction

NCT02672566

Fetal Growth Retardation

COMPLETED PHASE3

CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction

NCT04729361

IUGR Prenatal Disorder Genetic Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intrauterine Growth Restriction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HFME births.

All birth more than 24 + 0 weeks of amenorrhea at the maternity ward of the hospital Femme-Mère-Enfant from 1st of january 2011 to 31 december 2017.

Intrauterine growth restriction (IUGR)

Intervention Type OTHER

Collection of number of patient's diagnosed with IUGR as defined in accordance with the consensus-based definition for early and late IUGR : birthweight \< 3rd centile using French AUDIPOG curves adjusted for term and sex or estimated fetal weight \< 10th centile combined with umbilical artery pulsatility index \> 95th centile or breakage of growth.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.